Kiniksa Pharmaceuticals Reports Third Quarter 2024 Financial Results and Recent Portfolio Execution

Go back to Kiniksa Pharmaceuticals Reports Third Quarter 2024 Financial Results and Recent Portfolio Execution
(NASDAQ: KNSA) Delayed: 79.48 +0.89 (1.13%)
Previous Close $78.59    52 Week High $ 
Open $78.78    52 Week Low $ 
Day High $80.61    P/E N/A 
Day Low $78.36    EPS $ 
Volume 594,951